Susceptibility Artifact in Post-Operative Prostate Bed

The signal void and geometric distortion are most likely due to magnetic susceptibility artifacts from the right hip replacement. Metallic implants cause local magnetic field inhomogeneities, leading to signal loss and spatial distortion, particularly on gradient-echo sequences but also on spin-echo sequences if the field disturbance is severe. To confirm, review the CT images: the hip prosthesis should be visible. Also, inspect the MRI at the level of the artifact; the distortion often radiates from the implant. Additionally, check other sequences (e.g., DWI, DCE) for similar artifacts. If the artifact is limited to the right side and the prostate bed is centrally located, the central region may still be usable, but the distortion could extend. A quick test: acquire a fast gradient-echo sequence (e.g., spoiled gradient echo) which is more sensitive to susceptibility; if the artifact worsens, it confirms susceptibility. Also, consider using a spin-echo sequence with a wider bandwidth or short TE to reduce artifact, but the implant is outside the body; the artifact is due to the implant's effect on the static field. The best confirmation is to compare with CT and see if the artifact corresponds to the implant location.

To reduce susceptibility artifacts from a hip replacement at 1.5 T, several strategies can be employed: 1) Use spin-echo sequences (fast spin echo) instead of gradient-echo, as spin echo is less sensitive to static field inhomogeneities. 2) Increase the receiver bandwidth to reduce the echo time and thus the artifact. 3) Use a shorter TE. 4) Use a smaller voxel size (higher resolution) to reduce intravoxel dephasing, but this may increase scan time. 5) Apply parallel imaging to reduce readout time. 6) Use spectral fat saturation instead of inversion recovery. 7) Position the patient so that the implant is as far from the imaging volume as possible, but the hip is fixed. 8) Consider using a 3T scanner? Actually, higher field strength increases susceptibility, so 1.5T is better. 9) Use metal artifact reduction sequences (e.g., MAVRIC, SEMAC) if available, but these are more common for orthopedic implants and may not be available on all scanners. 10) Optimize shimming over the prostate bed. 11) Use a smaller field of view to focus on the prostate bed. 12) For DWI, use a single-shot EPI with a shorter TE and parallel imaging. For DCE, use a fast 3D gradient-echo with a short TE. The most practical: switch to fast spin-echo T2-weighted images with a wider bandwidth (e.g., 62.5 kHz) and a shorter TE (e.g., 80 ms instead of 100 ms), and use a smaller FOV (e.g., 20 cm) centered on the prostate bed. Also, consider acquiring a separate scan with the patient's legs elevated to move the hip further? Not practical. Instead, use a dedicated prostate coil if available. Finally, if artifact persists, consider CT-based delineation with MRI fusion only for the unaffected regions.

If MRI artifact from the hip replacement cannot be reduced, alternatives include: 1) Use CT for target delineation. CT can show the prostate bed but has poor soft-tissue contrast, making it difficult to distinguish fibrosis from recurrence. However, CT is not affected by magnetic susceptibility. 2) Use PET/CT with a prostate-specific radiotracer (e.g., PSMA PET) if available, which can help identify recurrence. 3) Use ultrasound? Not typically for simulation. 4) Use a different MRI sequence less affected, such as spin-echo with very wide bandwidth, but if still inadequate, then rely on CT. 5) Consider a repeat MRI with the patient positioned differently? Not feasible. 6) Use a 0.3T open MRI? Lower field reduces susceptibility but poor SNR. Limitations: CT lacks soft-tissue contrast, so delineation of the prostate bed may be uncertain, leading to larger margins and increased toxicity. PET has limited spatial resolution and may not be available. Ultrasound is operator-dependent and not used for simulation. Therefore, the best approach is to optimize MRI as much as possible, and if still inadequate, use CT with careful correlation with any available MRI (even if distorted, the central region may be usable) and consider using surgical clips as fiducials. The radiation oncologist should be informed of the limitation and may choose to treat with larger margins or use image guidance. Ultimately, the decision should be made jointly, weighing the risk of geographic miss versus increased toxicity.